EASL Liver Cancer Summit 2024
Centered on primary liver tumors, notably hepatocellular carcinoma (HCC) and biliary tract cancer (BTC), the summit delves into the intricate links with viral infections, alcohol misuse, and metabolic disorders, among an array of other remarkable program highlights.
Uniting a diverse spectrum of professionals including clinicians, researchers, nurses, patient advocates, and industry experts, this summit aspires to confront the challenges prevalent in clinical practice. By shedding light on recent revelations regarding the origins of these tumors and presenting cutting-edge advancements in diagnostics and treatment strategies, the EASL Liver Cancer Summit 2024 endeavors to make a substantial contribution to the ongoing enhancement of liver cancer care.